Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

27 Apr 2016 10:00

RNS Number : 5000W
Nplus1 Singer Capital Markets Ltd
27 April 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Skyepharma Plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Skyepharma Plc

 

(d) Date dealing undertaken:

26 April 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ Sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 100P

 

Purchase

 

28013

 

480p

 

470p

 

ORD 100P

 

Sale

 

6375

 

480p

 

480p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

27 April 2016

Contact name:

Damian Fernandez

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERKMGZDRNRGVZG
Date   Source Headline
1st Dec 20147:00 amRNSflutiform launch in Spain; Abriff launch in Italy
11th Nov 20144:42 pmRNSPresenting at two forthcoming investor conferences
10th Nov 20143:47 pmRNSHolding(s) in Company
4th Nov 20143:41 pmRNSDirector/PDMR Shareholding
20th Oct 20149:48 amRNSHolding(s) in Company
14th Oct 201410:12 amRNSHolding(s) in Company
9th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:52 pmRNSDirector/PDMR Shareholding
30th Sep 20145:55 pmRNSHolding(s) in Company
30th Sep 20143:51 pmRNSHolding(s) in Company
22nd Sep 20147:00 amRNSNotice of early repayment of Euro CRC Facility
11th Sep 201410:00 amRNSInnovation in Respiratory Diseases event
8th Sep 20147:00 amRNSflutiform phase III results in paediatric asthma
5th Sep 20144:05 pmRNSDirector/PDMR Shareholding
26th Aug 201410:46 amRNSHolding(s) in Company
22nd Aug 201411:43 amRNSHolding(s) in Company
22nd Aug 20149:40 amRNSHolding(s) in Company
21st Aug 201410:14 amRNSHolding(s) in Company
21st Aug 20147:00 amRNSHalf Yearly Report
13th Aug 20144:12 pmRNSAcquires a novel inhaled therapy platform
22nd Jul 201410:14 amRNSHolding(s) in Company
21st Jul 20143:31 pmRNSHolding(s) in Company
18th Jul 20147:00 amRNSNotice of Results
11th Jul 20146:12 pmRNSHolding(s) in Company
10th Jul 20148:05 amRNSDirector Declaration
23rd Jun 20145:44 pmRNSHolding(s) in Company
5th Jun 20147:00 amRNSPresents at Jefferies Global Healthcare Conference
22nd May 20141:32 pmRNSResult of AGM
16th May 20147:00 amRNSInterim Management Statement
14th May 20149:55 amRNSDirector/PDMR Shareholding
7th May 201410:57 amRNSHolding(s) in Company
2nd May 20144:01 pmRNSHolding(s) in Company
2nd May 20149:56 amRNSHolding(s) in Company
1st May 20144:23 pmRNSHolding(s) in Company
1st May 201411:42 amRNSHolding(s) in Company
30th Apr 20145:42 pmRNSHolding(s) in Company
30th Apr 20144:36 pmRNSHolding(s) in Company
29th Apr 20142:54 pmRNSHolding(s) in Company
29th Apr 20147:00 amRNSCompletion of Capital Raising and Admission
28th Apr 20143:43 pmRNSHolding(s) in Company
28th Apr 201411:59 amRNSResults of Offer and Proposal for Guaranteed Bonds
25th Apr 201411:15 amRNSResult of General Meeting and Directors Holdings
23rd Apr 20144:11 pmRNSHolding(s) in Company
23rd Apr 201410:01 amRNSHolding(s) in Company
22nd Apr 201412:04 pmRNSHolding(s) in Company
17th Apr 20147:00 amRNSResult of Placing & Open Offer
16th Apr 201410:00 amRNSHolding(s) in Company
15th Apr 201410:19 amRNSHolding(s) in Company
4th Apr 20143:09 pmRNSHolding(s) in Company
3rd Apr 20145:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.